Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity (Monoclonal, Polyclonal); By Type (FAB, scFv); By Therapy; By Application; By Region; Segment Forecast, 2022 - 2030

Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity (Monoclonal, Polyclonal); By Type (FAB, scFv); By Therapy; By Application; By Region; Segment Forecast, 2022 - 2030

The global antibody fragments market size is expected to reach USD 11.71 billion by 2030, according to a new study by Polaris Market Research. The report “Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity (Monoclonal, Polyclonal); By Type (FAB, scFv); By Therapy; By Application; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

The rising cases of cancer across the globe contribute to the growth of the antibody fragment, and soon the, it will replace the full-length antibody. These are smaller in size and can be easily penetrated, thus being used in the treatment of diseases such as cancer, tumors, and COVID-19.

In addition, the growing geriatric population across developing economies such as India, Japan, Mexico, and China will positively impact the demand for the industry over the coming years. However, with the development of second and third-generation, the demand for first-generation will reduce. The COVID-19 pandemic positively impacted the demand for the industry, as these are used in the treatment of COVID-19. The industry will continue to expand with increased diseases. With the smaller size of the antibody, it is used to cure tumors as well.

Antibody Fragments Market Report Highlights

  • The monoclonal antibodies dominated the industry owing to the antibodies’ homogeneous nature and production.
  • The immunodeficiency segment dominates the market with the increasing prevalence of diseases globally. FAB segment is the first-generation antibody molecule and thus is used at a higher level.
  • North America dominates the industry with the highest revenue share and is expected to grow with advanced infrastructure and technology over the forecast period.
  • Major players operating in the industry include Pfizer Inc.; Ablynx; Novartis AG; Genentech, Inc.; AbbVie Inc.; Bristol-Myers Squibb Company; Johnson & Johnson Private Limited; Eli Lilly, F. Hoffmann-La Roche AG; Amgen Inc.; The Takeda Pharmaceutical Company Limited; Sanofi S.A.; Biogen Inc.

  • Polaris Market Research has segmented the Antibody Fragments market report based on specificity, type, therapy, application, and region:

    Antibody Fragments, Specificity Outlook (Revenue – USD Billion, 2018 – 2030)
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    Antibody Fragments, Type Outlook (Revenue – USD Billion, 2018 – 2030)
    • FAB
    • scFv
    • sdAb
    • Others
    Antibody Fragments, Therapy Outlook (Revenue – USD Billion, 2018 – 2030)
    • Monoclonal Antibodies
    • PAB
    • Pipeline
    Antibody Fragments, Application Outlook (Revenue – USD Billion, 2018 – 2030)
    • Cancer
    • Immunodeficiency
    • Others
    Antibody Fragments, Regional Outlook (Revenue – USD Billion, 2018 – 2030)
    • North America
    • U.S.
    • Canada
    • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
    • Latin America
    • Argentina
    • Brazil
    • Mexico
    • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa


    1. Introduction
    1.1. Report Description
    1.1.1. Objectives of the Study
    1.1.2. Market Scope
    1.1.3. Assumptions
    1.2. Stakeholders
    2. Executive Summary
    2.1. Market Highlights
    3. Research Methodology
    3.1. Overview
    3.1.1. Data Mining
    3.2. Data Sources
    3.2.1. Primary Sources
    3.2.2. Secondary Sources
    4. Global Antibody Fragments Market Insights
    4.1. Antibody Fragments – Industry Snapshot
    4.2. Antibody Fragments Market Dynamics
    4.2.1. Drivers and Opportunities
    4.2.1.1. Increasing prevalence of infectious and chronic diseases
    4.2.1.2. Antibody fragments are preferred over other alternatives
    4.2.2. Restraints and Challenges
    4.2.2.1. Obstacles in the purification of antibody fragments
    4.3. Porter’s Five Forces Analysis
    4.3.1. Bargaining Power of Suppliers (Moderate)
    4.3.2. Threats of New Entrants: (Low)
    4.3.3. Bargaining Power of Buyers (Moderate)
    4.3.4. Threat of Substitute (Moderate)
    4.3.5. Rivalry among existing firms (High)
    4.4. PESTLE Analysis
    4.5. Antibody Fragments Industry Trends
    4.6. Value Chain Analysis
    4.7. COVID-19 Impact Analysis
    5. Global Antibody Fragments Market, by Specificity
    5.1. Key Findings
    5.2. Introduction
    5.2.1. Global Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    5.3. Monoclonal Antibodies
    5.3.1. Global Antibody Fragments Market, by Monoclonal Antibodies, by Region, 2018 - 2030 (USD Billion)
    5.4. Polyclonal Antibodies
    5.4.1. Global Antibody Fragments Market, by Polyclonal Antibodies, by Region, 2018 - 2030 (USD Billion)
    6. Global Antibody Fragments Market, by Type
    6.1. Key Findings
    6.2. Introduction
    6.2.1. Global Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    6.3. FAB
    6.3.1. Global Antibody Fragments Market, by FAB, by Region, 2018 - 2030 (USD Billion)
    6.4. scFv
    6.4.1. Global Antibody Fragments Market, by scFv, by Region, 2018 - 2030 (USD Billion)
    6.5. sdAb
    6.5.1. Global Antibody Fragments Market, by sdAb, by Region, 2018 - 2030 (USD Billion)
    6.6. Others
    6.6.1. Global Antibody Fragments Market, by Others, by Region, 2018 - 2030 (USD Billion)
    7. Global Antibody Fragments Market, by Therapy
    7.1. Key Findings
    7.2. Introduction
    7.2.1. Global Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    7.3. Monoclonal Antibodies
    7.3.1. Global Antibody Fragments Market, by Monoclonal Antibodies, by Region, 2018 - 2030 (USD Billion)
    7.4. PAB
    7.4.1. Global Antibody Fragments Market, by PAB, by Region, 2018 - 2030 (USD Billion)
    7.5. Pipeline
    7.5.1. Global Antibody Fragments Market, by Pipeline, by Region, 2018 - 2030 (USD Billion)
    8. Global Antibody Fragments Market, by Application
    8.1. Key Findings
    8.2. Introduction
    8.2.1. Global Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    8.3. Cancer
    8.3.1. Global Antibody Fragments Market, by Cancer, by Region, 2018 - 2030 (USD Billion)
    8.4. Immunodeficiency
    8.4.1. Global Antibody Fragments Market, by Immunodeficiency, by Region, 2018 - 2030 (USD Billion)
    8.5. Others
    8.5.1. Global Antibody Fragments Market, by Others, by Region, 2018 - 2030 (USD Billion)
    9. Global Antibody Fragments Market, by Geography
    9.1. Key findings
    9.2. Introduction
    9.2.1. Antibody Fragments Market Assessment, By Geography, 2018 - 2030 (USD Billion)
    9.3. Antibody Fragments Market – North America
    9.3.1. North America: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.3.2. North America: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.3.3. North America: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.3.4. North America: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.3.5. Antibody Fragments Market – U.S.
    9.3.5.1. U.S.: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.3.5.2. U.S.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.3.5.3. U.S.: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.3.5.4. U.S.: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.3.6. Antibody Fragments Market – Canada
    9.3.6.1. Canada: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.3.6.2. Canada: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.3.6.3. Canada: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.3.6.4. Canada: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4. Antibody Fragments Market – Europe
    9.4.1. Europe: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.2. Europe: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.3. Europe: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.4. Europe: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.5. Antibody Fragments Market – UK
    9.4.5.1. UK: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.5.2. UK: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.5.3. UK: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.5.4. UK: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.6. Antibody Fragments Market – France
    9.4.6.1. France: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.6.2. France: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.6.3. France: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.6.4. France: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.7. Antibody Fragments Market – Germany
    9.4.7.1. Germany: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.7.2. Germany: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.7.3. Germany: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.7.4. Germany: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.8. Antibody Fragments Market – Italy
    9.4.8.1. Italy: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.8.2. Italy: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.8.3. Italy: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.8.4. Italy: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.9. Antibody Fragments Market – Spain
    9.4.9.1. Spain: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.9.2. Spain: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.9.3. Spain: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.9.4. Spain: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.10. Antibody Fragments Market – Netherlands
    9.4.10.1. Netherlands: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.10.2. Netherlands: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.10.3. Netherlands: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.10.4. Netherlands: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.4.11. Antibody Fragments Market – Russia
    9.4.11.1. Russia: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.4.11.2. Russia.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.4.11.3. Russia: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.4.11.4. Russia: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5. Antibody Fragments Market – Asia Pacific
    9.5.1. Asia Pacific: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.2. Asia Pacific: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.3. Asia Pacific: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.4. Asia Pacific: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5.5. Antibody Fragments Market – China
    9.5.5.1. China: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.5.2. China.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.5.3. China: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.5.4. China: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5.6. Antibody Fragments Market – India
    9.5.6.1. India: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.6.2. India.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.6.3. India: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.6.4. India: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5.7. Antibody Fragments Market – Japan
    9.5.7.1. Japan: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.7.2. Japan.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.7.3. Japan: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.7.4. Japan: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5.8. Antibody Fragments Market – Malaysia
    9.5.8.1. Malaysia: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.8.2. Malaysia.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.8.3. Malaysia: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.8.4. Malaysia: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5.9. Antibody Fragments Market – Indonesia
    9.5.9.1. Indonesia: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.9.2. Indonesia.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.9.3. Indonesia: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.9.4. Indonesia: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.5.10. Antibody Fragments Market – South Korea
    9.5.10.1. South Korea: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.5.10.2. South Korea.: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.5.10.3. South Korea: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.5.10.4. South Korea: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.6. Antibody Fragments Market – Middle East & Africa
    9.6.1. Middle East & Africa: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.6.2. Middle East & Africa: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.6.3. Middle East & Africa: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.6.4. Middle East & Africa: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.6.5. Antibody Fragments Market – Saudi Arabia
    9.6.5.1. Saudi Arabia: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.6.5.2. Saudi Arabia: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.6.5.3. Saudi Arabia: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.6.5.4. Saudi Arabia: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.6.6. Antibody Fragments Market – South Africa
    9.6.6.1. South Africa: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.6.6.2. South Africa: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.6.6.3. South Africa: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.6.6.4. South Africa: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.6.7. Antibody Fragments Market – Israel
    9.6.7.1. Israel: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.6.7.2. Israel: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.6.7.3. Israel: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.6.7.4. Israel: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.6.8. Antibody Fragments Market – UAE
    9.6.8.1. UAE: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.6.8.2. UAE: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.6.8.3. UAE: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.6.8.4. UAE: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.7. Antibody Fragments Market – Latin America
    9.7.1. Latin America: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.7.2. Latin America: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.7.3. Latin America: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.7.4. Latin America: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.7.5. Antibody Fragments Market – Mexico
    9.7.5.1. Mexico: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.7.5.2. Mexico: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.7.5.3. Mexico: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.7.5.4. Mexico: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.7.6. Antibody Fragments Market – Brazil
    9.7.6.1. Brazil: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.7.6.2. Brazil: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.7.6.3. Brazil: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.7.6.4. Brazil: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    9.7.7. Antibody Fragments Market – Argentina
    9.7.7.1. Argentina: Antibody Fragments Market, by Specificity, 2018 - 2030 (USD Billion)
    9.7.7.2. Argentina: Antibody Fragments Market, by Application, 2018 - 2030 (USD Billion)
    9.7.7.3. Argentina: Antibody Fragments Market, by Type, 2018 - 2030 (USD Billion)
    9.7.7.4. Argentina: Antibody Fragments Market, by Therapy, 2018 - 2030 (USD Billion)
    10. Competitive Landscape
    10.1. Expansion and Acquisition Analysis
    10.1.1. Expansion
    10.1.2. Acquisitions
    10.2. Partnerships/Collaborations/Agreements/Exhibitions
    11. Company Profiles
    11.1. Pfizer Inc.
    11.1.1. Company Overview
    11.1.2. Financial Performance
    11.1.3. Type Benchmarking
    11.1.4. Recent Development
    11.2. Ablynx
    11.2.1. Company Overview
    11.2.2. Financial Performance
    11.2.3. Type Benchmarking
    11.2.4. Recent Development
    11.3. Novartis AG
    11.3.1. Company Overview
    11.3.2. Financial Performance
    11.3.3. Type Benchmarking
    11.3.4. Recent Development
    11.4. Genentech, Inc.
    11.4.1. Company Overview
    11.4.2. Financial Performance
    11.4.3. Type Benchmarking
    11.4.4. Recent Development
    11.5. AbbVie Inc.
    11.5.1. Company Overview
    11.5.2. Financial Performance
    11.5.3. Type Benchmarking
    11.5.4. Recent Development
    11.6. Bristol-Myers Squibb Company
    11.6.1. Company Overview
    11.6.2. Financial Performance
    11.6.3. Type Benchmarking
    11.6.4. Recent Development
    11.7. Johnson & Johnson Private Limited
    11.7.1. Company Overview
    11.7.2. Financial Performance
    11.7.3. Type Benchmarking
    11.7.4. Recent Development
    11.8. Eli Lilly
    11.8.1. Company Overview
    11.8.2. Financial Performance
    11.8.3. Type Benchmarking
    11.8.4. Recent Development
    11.9. F. Hoffmann-La Roche AG
    11.9.1. Company Overview
    11.9.2. Financial Performance
    11.9.3. Type Benchmarking
    11.9.4. Recent Development
    11.10. Amgen Inc.
    11.10.1. Company Overview
    11.10.2. Financial Performance
    11.10.3. Type Benchmarking
    11.10.4. Recent Development
    11.11. The Takeda Pharmaceutical Company Limited
    11.11.1. Company Overview
    11.11.2. Financial Performance
    11.11.3. Type Benchmarking
    11.11.4. Recent Development
    11.12. Sanofi S.A.
    11.12.1. Company Overview
    11.12.2. Financial Performance
    11.12.3. Type Benchmarking
    11.12.4. Recent Development
    11.13. Biogen Inc.
    11.13.1. Company Overview
    11.13.2. Financial Performance
    11.13.3. Type Benchmarking
    11.13.4. Recent Development

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings